S100A8 and metabolic dysfunction-associated steatohepatitis: Interestingly, this up-regulation of calprotectin (S100A8/A9) is the opposite of the observed down-regulation of calprotectin in mice during obesity-related NASH, indicating a potential species-specific divergence.